Bertrand Arnulf, MD, PhD (he/him/his)

Professor
Service d'Immunologie Hématologie Hôpital Saint-Louis
Paris, Ile-de-France, France

Bertrand Arnulf, MD, PhD

Birth date : 20 APR 1964

Professor of Clinical Immunology, University Paris Cité & Immuno-Hématology department, Hôpital Saint Louis, APHP, Paris.

Head of the Immuno-hematology department of Saint Louis hospital dedicated to Monoclonal gammopathies and related disorders including Multiple Myeloma, Waldenström Macroglobulinemia, Monoclonal gammopathies of Clinical significance and AL amyloidosis. National reference center for AL amyloidosis and other monoclonal gammopathy of clinical significance
Active member of IFM board. Coordinator Myeloma part of the DESCAR-T registry and the CAR-T program of IFM
Basic and translational research focused on novel immunotherapies in Multiple Myeloma and involved in main CAR T studies in development

Disclosure information not submitted.

Presentation(s):

• (OA-65) Farorable Outcome of Relapsed/Refractory Multiple Myeloma treated with Idecabtagene Vicleucel (Ide-cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy; IFM experience from the Descar-T Registry

  Thursday, September 18, 2025
  15:00 - 15:08 East Coast USA Time